Radical Changes in Carbapenemase-Producing Enterobacterales in Poland During the COVID-19 Pandemic and War in Ukraine
In brief
Carbapenemase-producing bacteria in Poland rose 153%, then diversified into new genotypes
Among 10,339 isolates collected in Poland from 2019 to 2024, carbapenemase-producing Enterobacterales rose about 153% from 2019 to 2021, then another 36% from 2022 to 2024. The dominant Klebsiella strain fell from over 70% to about 15%, and around 30% of 2024 isolates carried hypervirulence genes; the descriptive study cannot show whether COVID-19 or the war drove these changes.
- Journal
- Infectious diseases and therapy (Q1)
- Published
- 10 November 2026
- Study design
- Unclassified
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- Radosław Izdebski, Marta Biedrzycka, Małgorzata Grzegorczyk, Paweł Grzesiowski, Waleria Hryniewicz, Dorota Żabicka, et al.
- PMID
- 43007395
- DOI
- 10.1007/s40121-026-01481-7
Why clinicians should know about it
- Picked for Microbiology (medical) (top studies of the week, 15 November 2026): National carbapenemase epidemiology with PCR and genomic surveillance
Abstract
INTRODUCTION: A marked increase in carbapenemase-producing Enterobacterales (CPE) occurred in Poland during COVID-19 and full-scale war in Ukraine. This study aimed to descriptively analyze the characteristics of the growing number of CPE in the country. METHODS: In 2019-2024, 10,339 unique CPE isolates were collected. First, this study included an analysis of isolate and patient data. Then, 1130 Klebsiella pneumoniae isolates from July to September 2019, 2021 and 2024 were screened by PCR for hypervirulence (hvKp) genes. All PCR-positive isolates plus representative negatives (n = 639) were sequenced and analysed with bioinformatic tools. RESULTS: CPE increased biphasically, with ~ 153% growth in 2019-2021 and ~ 36% in 2022-2024. During COVID-19, the increase retained the clonality and carbapenemase content of K. pneumoniae, with the predominant (> 70%) NDM-1-producing ST11 genotype, present since 2012/2013. Otherwise, in 2022-2024, the ST11 decreased to ~15%, owing to multiple clones/genotypes, including ST147, ST307 and ST395. Around 30% of the 2024 isolates carried hvKp genes. In 2022, multiple new genotypes were identified originally in Poland, Germany or elsewhere from Ukrainian patients. CONCLUSIONS: The study provided a recent view of CPE epidemiology in Poland and also highlighted the risk of further expansion of dangerous organisms from Eastern Europe.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.